You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 1, 2026
Sale
Calculated transaction value
$62.58K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 30, 2026
Public filing date
Oct 1, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$541.89
Sep 30, 2026
First close after public filing
$541.7
Oct 2, 2026
30-day return after filing
+10.05%
Through Nov 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 113 shares @ $553.78
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000154
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$1.06M
Buys / sales
0 / 8
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $66.32K |
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $218.92K |
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $131.86K |
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $88.24K |
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $114.82K |
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $220.19K |
| United Therapeutics Corp UTHR | Sale | Sep 30, 2026 | $153.51K |
| United Therapeutics Corp UTHR Current | Sale | Sep 30, 2026 | $62.58K |